18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial

Controlled Trial ◽

Conventional Imaging ◽

Phase 2 ◽

Single Centre ◽

Open Label ◽

Pet Ct ◽

Open Label Phase ◽

Faculty Opinions recommendation of Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726215272.793539632 ◽

2017 ◽

Author(s):

Patrick Nana-Sinkam

Keyword(s):

Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Open Label Phase ◽

Previously Treated ◽

Advanced Reperfusion Strategies for Patients with Out-of-Hospital Cardiac Arrest and Refractory Ventricular Fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial

Journal of Emergency Medicine ◽

10.1016/j.jemermed.2021.04.002 ◽

2021 ◽

Vol 60 (5) ◽

pp. 695

Author(s):

Anne Kathryn Watson ◽

Zachary B. Lewis

Keyword(s):

Cardiac Arrest ◽

Controlled Trial ◽

Phase 2 ◽

Single Centre ◽

Open Label ◽

Randomised Controlled ◽

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

The Lancet Rheumatology ◽

10.1016/s2665-9913(20)30341-6 ◽

2020 ◽

Vol 2 (12) ◽

pp. e764-e773 ◽

Cited By ~ 9

Author(s):

Alexander P J Vlaar ◽

Sanne de Bruin ◽

Matthias Busch ◽

Sjoerd A M E G Timmermans ◽

Ingeborg E van Zeggeren ◽

...

Keyword(s):

Supportive Care ◽

Controlled Trial ◽

Best Supportive Care ◽

Phase 2 ◽

Open Label ◽

Open Label Phase ◽

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(20)30448-3 ◽

2021 ◽

Author(s):

Robert S Wallis ◽

Sibuse Ginindza ◽

Trevor Beattie ◽

Nishanee Arjun ◽

Modulakgotla Sebe ◽

...

Keyword(s):

Pulmonary Tuberculosis ◽

Controlled Trial ◽

Phase 2 ◽

Open Label ◽

Open Label Phase ◽

Advanced Reperfusion Strategies for Patients with Out-of-Hospital Cardiac Arrest and Refractory Ventricular Fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial

Journal of Emergency Medicine ◽

10.1016/j.jemermed.2021.05.018 ◽

2021 ◽

Vol 60 (6) ◽

pp. 825

Author(s):

Anne Kathryn Watson ◽

Zachary B. Lewis

Keyword(s):

Cardiac Arrest ◽

Controlled Trial ◽

Phase 2 ◽

Single Centre ◽

Open Label ◽

Randomised Controlled ◽

Faculty Opinions recommendation of Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739060566.793582815 ◽

2021 ◽

Author(s):

Andrew Smith ◽

Jan Hansel

Keyword(s):

Cardiac Arrest ◽

Controlled Trial ◽

Phase 2 ◽

Single Centre ◽

Open Label ◽

Randomised Controlled ◽

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(16)00587-0 ◽

2016 ◽

Vol 387 (10030) ◽

pp. 1837-1846 ◽

Cited By ~ 1206

Author(s):

Louis Fehrenbacher ◽

Alexander Spira ◽

Marcus Ballinger ◽

Marcin Kowanetz ◽

Johan Vansteenkiste ◽

...

Keyword(s):

Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Open Label Phase ◽

Previously Treated ◽

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(20)32338-2 ◽

2020 ◽

Vol 396 (10265) ◽

pp. 1807-1816 ◽

Cited By ~ 4

Author(s):

Demetris Yannopoulos ◽

Jason Bartos ◽

Ganesh Raveendran ◽

Emily Walser ◽

John Connett ◽

...

Keyword(s):

Cardiac Arrest ◽

Controlled Trial ◽

Phase 2 ◽

Single Centre ◽

Open Label ◽

Randomised Controlled ◽

Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO

SSRN Electronic Journal ◽

10.2139/ssrn.3478102 ◽

2019 ◽

Author(s):

Chiara Cremolini ◽

Carlotta Antoniotti ◽

Daniele Rossini ◽

Sara Lonardi ◽

Fotios Loupakis ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(21)00160-0 ◽

2021 ◽

Author(s):

Sanjay Ramakrishnan ◽

Dan V Nicolau ◽

Beverly Langford ◽

Mahdi Mahdi ◽

Helen Jeffers ◽

...

Keyword(s):

Controlled Trial ◽

Phase 2 ◽

Open Label ◽

Inhaled Budesonide ◽